Walk down any aisle of any store and read the labels. Natural. Clean. Boosts immunity. Doctor-recommended. Sustainably sourced. Each of these phrases sounds like it has been verified by someone with authority, and most of them have not. Consumers tend to assume that if a claim were not true, the government would not let it appear on a package. That assumption is wrong, and it is wrong in a structurally important way that the regulatory system has not closed in decades.
The legal definition of “regulated” is doing a lot of work
In the United States, claims about products fall into a tiered system that consumers rarely understand. Drug claims, the kind that say a product treats or cures a specific disease, are tightly regulated and require clinical trials. Almost everything else is much looser. Structure-function claims, like “supports immune health” or “promotes heart health,” can appear on supplements without efficacy data, as long as a small disclaimer notes the FDA has not evaluated the statement. Marketing terms like “natural,” “clean,” “pure,” and “premium” have essentially no legal definition for most product categories. “Organic” is regulated, and is the exception that proves the rule. Even “Made in USA” is policed inconsistently. The regulatory framework is not absent, but it was built for an earlier marketing environment and has not been updated for one in which most claims are deliberately phrased to fall in the unregulated gaps.
Enforcement is reactive, slow, and underfunded
Even where regulations technically apply, enforcement depends on agencies that are perpetually understaffed relative to the scale of the market. The FTC, which polices deceptive advertising, brings a few hundred cases per year against a marketplace with millions of products. The FDA’s warning-letter process for misleading supplement claims typically takes years from complaint to action, by which point the product has often been reformulated or rebranded. State attorneys general fill some of the gap, but inconsistently. The practical effect is that companies treat the expected cost of an enforcement action as an operating expense rather than a deterrent. If you can sell a product for three years before being told to change the label, the math usually works in the company’s favor.
The financial-services version is just as serious
The same dynamic shows up in finance. “Fiduciary,” “advisor,” “fee-only,” and “independent” mean different things in different contexts, and the differences are often the entire point of using one term over another. Most consumers cannot reliably distinguish between a registered investment advisor and a broker-dealer representative, even though the legal duties owed to the client are dramatically different. Disclosures exist, but they are designed to satisfy lawyers, not inform readers. The result is a market in which the language of trustworthiness is more strictly regulated than the underlying behavior, which is roughly the opposite of what consumers assume.
Bottom line
Treat unfamiliar claims as marketing until proven otherwise. The regulators are real but spread thin, and most of what looks like authority is the absence of an objection nobody had bandwidth to raise. Skepticism is not paranoia. It is calibration.
Leave a Reply